UNIIQ invests €200,000 in novel cancer therapeutics startup BIMINI Biotech
Leiden, 26 November 2020 – BIMINI Biotech, an innovative therapeutics startup that develops new cancer drugs, has secured an investment of €200,000 from proof-of-concept fund UNIIQ to further develop its technology. The company aims to use the growth hormone receptor to uniquely inhibit cancer cell… Lees verder »UNIIQ invests €200,000 in novel cancer therapeutics startup BIMINI Biotech